ES2010513B3 - Nuevos derivados de 6- o 7-metilenoandrosta-1,4-dieno3,17-diona y procedimiento para su preparacion. - Google Patents

Nuevos derivados de 6- o 7-metilenoandrosta-1,4-dieno3,17-diona y procedimiento para su preparacion.

Info

Publication number
ES2010513B3
ES2010513B3 ES87306125T ES87306125T ES2010513B3 ES 2010513 B3 ES2010513 B3 ES 2010513B3 ES 87306125 T ES87306125 T ES 87306125T ES 87306125 T ES87306125 T ES 87306125T ES 2010513 B3 ES2010513 B3 ES 2010513B3
Authority
ES
Spain
Prior art keywords
dieno3
anrosta
diona
methylene
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES87306125T
Other languages
English (en)
Inventor
Salle Enrico Di
Natale Barbugian
Paolo Lombardi
Franco Buzzetti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Carlo Erba SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL, Carlo Erba SpA filed Critical Farmitalia Carlo Erba SRL
Application granted granted Critical
Publication of ES2010513B3 publication Critical patent/ES2010513B3/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/008—Ketals at position 17
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A NUEVAS 6- O 7METILENOANDROSTA-1,4-DIENO-3,17-DIONAS DE LA FORMULA SIGUIENTE (I) EN LA QUE R ES HIDROGENO O FLUOR; R1 ES HIDROGENO O ALQUILO DE 1 A 6 CARBONOS; R2 ES HIDROGENO O HALOGENO; UNA DE LAS R3 Y R4 ES = CH2 Y LA OTRA ES HIDROGENO O ALQUILO DE 1 A 4 CARBONOS, Y CUANDO R3 ES =CH2, POR LO MENOS UNA DE LAS R Y R4 ES DISTINTA DE HIDROGENO; Y EL SIMBOLO = (X) = REPRESENTA UN DOBLE ENLACE, Y EL SIMBOLO = (Y) = REPRESENTA UN ENLACE SENCILLO CUANDO R3 ES = CH2, O EL SIMBOLO = (X) = REPRESENTA UN ENLACE SENCILLO, Y EL SIMBOLO = (Y) = REPRESENTA UN DOBLE ENLACE CUANDO R4 ES =CH2, QUE SON UTILES EN TERAPIA, EN PARTICULAR, COMO AGENTES ANTICANCEROSOS.
ES87306125T 1986-07-14 1987-07-10 Nuevos derivados de 6- o 7-metilenoandrosta-1,4-dieno3,17-diona y procedimiento para su preparacion. Expired ES2010513B3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868617107A GB8617107D0 (en) 1986-07-14 1986-07-14 6-/7-methylenandrosta-1 4-diene-3 17-dione derivatives

Publications (1)

Publication Number Publication Date
ES2010513B3 true ES2010513B3 (es) 1989-11-16

Family

ID=10601019

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87306125T Expired ES2010513B3 (es) 1986-07-14 1987-07-10 Nuevos derivados de 6- o 7-metilenoandrosta-1,4-dieno3,17-diona y procedimiento para su preparacion.

Country Status (24)

Country Link
US (1) US4824830A (es)
EP (1) EP0253591B1 (es)
JP (1) JP2643943B2 (es)
CN (1) CN87104750A (es)
AT (1) ATE44282T1 (es)
AU (1) AU589269B2 (es)
CA (1) CA1309400C (es)
CS (1) CS262695B2 (es)
DE (1) DE3760277D1 (es)
DK (1) DK364787A (es)
ES (1) ES2010513B3 (es)
FI (1) FI873052A (es)
GB (1) GB8617107D0 (es)
GR (1) GR3000085T3 (es)
HU (1) HU196223B (es)
IL (1) IL83132A (es)
MY (1) MY100512A (es)
NO (1) NO872892D0 (es)
NZ (1) NZ221012A (es)
PH (1) PH22994A (es)
PT (1) PT85318B (es)
SU (1) SU1549485A3 (es)
YU (1) YU45827B (es)
ZA (1) ZA875098B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5719448A (en) * 1989-03-07 1998-02-17 Seiko Epson Corporation Bonding pad structures for semiconductor integrated circuits
US5227375A (en) * 1990-02-08 1993-07-13 Endorecherche, Inc. Aromatase inhibitors
JP2602456B2 (ja) * 1990-04-12 1997-04-23 雪印乳業株式会社 子宮内膜症治療剤
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
GB9217035D0 (en) * 1992-08-11 1992-09-23 Erba Carlo Spa Androst-4-eno(4,5-b)pyrrole derivatives and process for their preparation
NZ261123A (en) * 1993-02-18 1996-08-27 Erba Carlo Spa Fluorinated 4-aminoandrostadienone derivatives
GB9313420D0 (en) * 1993-06-29 1993-08-11 Erba Carlo Spa Fluorinated 6-methylenandrosta-1,4-dien-3-one-derivatives and process for their preparations
FI109641B (fi) * 2000-03-10 2002-09-13 Nokia Corp Mikrofonirakenne
DK1377298T3 (da) * 2001-01-26 2007-01-02 Pfizer Italia Srl Exemestan til behandling af hormon-afhængige lidelser
US20040082557A1 (en) * 2001-01-26 2004-04-29 Wajszczuk Charles Paul Methods for treating estrogen-dependent disorders
US20050101581A1 (en) * 2002-08-28 2005-05-12 Reading Christopher L. Therapeutic treatment methods 2
US8183401B2 (en) * 2004-01-16 2012-05-22 Cedarburg Pharmaceuticals, Inc. Exemestane and its intermediates and methods of making the same
US20080275259A1 (en) * 2007-05-04 2008-11-06 Scinopharm Taiwan, Ltd Process for preparing aromatase inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB929985A (es) *
US2744120A (en) * 1953-01-14 1956-05-01 Olin Mathieson 1-dehydrotestololactone
US4235893A (en) * 1978-05-08 1980-11-25 Brodie Angela M Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis
DE3322285A1 (de) * 1983-06-18 1984-12-20 Schering AG, 1000 Berlin und 4709 Bergkamen 1-alkyl-androsta-1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
DE3485093D1 (de) * 1984-12-28 1991-10-24 Ibm Zuechtungsverfahren und vorrichtung zur herstellung von siliciumkristallen mit hohem und kontrolliertem kohlenstoffgehalt.
GB8517360D0 (en) * 1985-07-09 1985-08-14 Erba Farmitalia Substituted androsta-1,4-diene-3,17-diones
JPH0718729B2 (ja) * 1990-06-11 1995-03-06 山武ハネウエル株式会社 ヒータ温度制御回路

Also Published As

Publication number Publication date
GB8617107D0 (en) 1986-08-20
FI873052A0 (fi) 1987-07-10
SU1549485A3 (ru) 1990-03-07
DK364787A (da) 1988-01-15
PT85318B (pt) 1990-04-30
DK364787D0 (da) 1987-07-13
PH22994A (en) 1989-02-24
IL83132A (en) 1992-01-15
ZA875098B (en) 1988-03-30
FI873052A (fi) 1988-01-15
AU589269B2 (en) 1989-10-05
CA1309400C (en) 1992-10-27
PT85318A (en) 1987-08-01
JPS6323895A (ja) 1988-02-01
HUT44038A (en) 1988-01-28
IL83132A0 (en) 1987-12-31
DE3760277D1 (en) 1989-08-03
YU129487A (en) 1988-10-31
US4824830A (en) 1989-04-25
AU7550887A (en) 1988-01-21
GR3000085T3 (en) 1990-10-31
NO872892D0 (no) 1987-07-10
YU45827B (sh) 1992-07-20
ATE44282T1 (de) 1989-07-15
MY100512A (en) 1990-10-30
CN87104750A (zh) 1988-03-23
CS535087A2 (en) 1988-08-16
NZ221012A (en) 1989-05-29
EP0253591B1 (en) 1989-06-28
JP2643943B2 (ja) 1997-08-25
EP0253591A1 (en) 1988-01-20
HU196223B (en) 1988-10-28
CS262695B2 (en) 1989-03-14

Similar Documents

Publication Publication Date Title
ES2010513B3 (es) Nuevos derivados de 6- o 7-metilenoandrosta-1,4-dieno3,17-diona y procedimiento para su preparacion.
BG102701A (en) 2-hetaroylcyclohexan-1,3-dions
FI884088A0 (fi) Foerfarande foer framstaellning av 17-substituerade androsta-1,4-dien-3-onderivat.
NZ217719A (en) Oxadiazole and thiadiazole derivatives and nematocidal compositions
BG103271A (en) Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means
AU584225B2 (en) Steroidic aromatase inhibitors
SE8702527D0 (sv) Metylenderivat av androst-4-en-3,17-dioner och forfarande for deras framstellning